These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17228459)

  • 21. Virology. Moving forward in HIV vaccine development.
    Letvin NL
    Science; 2009 Nov; 326(5957):1196-8. PubMed ID: 19965456
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
    Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
    J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIDS clinical research for New Yorkers.
    GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300
    [No Abstract]   [Full Text] [Related]  

  • 28. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study released on AIDS vaccine results from Thailand.
    AIDS Alert; 2009 Dec; 24(12):139. PubMed ID: 20063476
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
    Ensoli B; Fiorelli V; Ensoli F; Lazzarin A; Visintini R; Narciso P; Di Carlo A; Monini P; Magnani M; Garaci E
    AIDS; 2008 Oct; 22(16):2207-9. PubMed ID: 18832884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART?
    Cianchetta-Sívori M; Raso S; Fernández-Guerrero M; Górgolas M; García R
    AIDS; 2007 Nov; 21(17):2347-9. PubMed ID: 18090286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.
    Longo O; Tripiciano A; Fiorelli V; Bellino S; Scoglio A; Collacchi B; Alvarez MJ; Francavilla V; Arancio A; Paniccia G; Lazzarin A; Tambussi G; Din CT; Visintini R; Narciso P; Antinori A; D'Offizi G; Giulianelli M; Carta M; Di Carlo A; Palamara G; Giuliani M; Laguardia ME; Monini P; Magnani M; Ensoli F; Ensoli B
    Vaccine; 2009 May; 27(25-26):3306-12. PubMed ID: 19208456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV hope ride on therapeutic vaccine.
    AIDS Read; 2005 Jul; 15(7):332. PubMed ID: 16044573
    [No Abstract]   [Full Text] [Related]  

  • 35. Study finds HIV subtly damages vision.
    TreatmentUpdate; 2001 Sep; 13(5):3-4. PubMed ID: 11768861
    [No Abstract]   [Full Text] [Related]  

  • 36. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
    Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity.
    Su J; Willert C; Comanita L; Peters A; Gilbert PA; Strathdee C; O'Connell PJ; McFadden GD; Dekaban GA
    Virology; 2008 May; 375(1):48-58. PubMed ID: 18291435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Viral loads in pediatric HIV patients with antiretroviral treatment].
    Porto-Espinoza L; Moronta R; Cuadra-Sánchez C; Callejas-Valero D; Costa-León L; Monsalve-Castillo F; Bernardoni C; Estévez J
    Rev Med Chil; 2008 Aug; 136(8):1021-6. PubMed ID: 18949186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.